Pathologic complete response after gemcitabine and S-1 chemotherapy for far advanced intrahepatic cholangiocarcinoma

Khan SA, Toledano MB, Taylor-Robinson SD et al (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10:77–82

Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357

Khan SA, Thomas HC, Davidson BR et al (2005) Cholangiocarcinoma. Lancet 366(9493):1303–1314

Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128(6):1655–1667

Murakami S, Ajiki T, Okazaki T et al (2014) Factors affecting survival after resection of intrahepatic cholangiocarcinoma. Surg Today 44:1847–1854

Schlinker RT, Nagorney DM, Van Heerden JA et al (1992) Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg 5:95–101

Weber SM, Jarnagin WR, Klimstra D et al (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193:384–91

Tajima Y, Kuroki T, Fukuda K et al (2004) An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 91:99–104

Yamashita Y, Taketomi A, Morita K et al (2008) The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 28(4C):2353–2359

de Jong MC, Nathan H, Sotiropoulos GC et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29(23):3140–3145

Uchiyama K, Yamamoto M, Yamaue H et al (2011) Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatibiliary Pancreat Sci 18(3):443–52

Inoue K, Makuuchi M, Takayama T et al (2000) Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127(5):498–505

Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16(11):3048–3056

Li DY, Zhang HB, Yang N et al (2013) Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol 19(47):9084–9091

Marubashi S, Gotoh K, Takahashi H et al (2014) Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively-determined anatomic invasion level and number of tumors. Dig Dis Sci 59(1):201–13

Yamamoto M, Takasaki K, Yoshikawa T (1999) Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6(2): 117–21

Kobayashi S, Gotoh K, Takahashi H et al (2016) Clinicopathological features of surgically-resected biliary tract cancer following chemo-radiation therapy. Anticancer Res 36(1):335–42

Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281

Nakamura K, Yamaguchi T, Ishihara T et al (2005) Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. Br J Cancer 92(12):2134–2139

Sasaki T, Isayama H, Nakai Y et al (2010) Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 65(6):1101–1107

Kato A, Shimizu H, Ohtsuka M et al (2015) Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol 22:S1093-9

Slupski MW, Szczylik C, Jasinski MK (2007) Unexpected response to systemic chemotherapy in case of primary nonresectable advanced disseminated intrahepatic cholangiocarcinoma. World J Surg Oncol 5:36

Tran TB, Bal CK, Schaberg K et al (2015) Locally advanced intrahepatic cholangiocarcinoma: complete pathologic response to neoadjuvant chemotherapy followed by left hepatic trisectionectomy and caudate lobectomy. Dig Dis Sci 60(11):3226–3229

Donahue JM, Nochols FC, Li Z et al (2009) Complete pathologic response after neoadjuvant chemotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 87(2):392–398

Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R et al (2012) Pathological complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol 16(1):29–37

Zorcolo L, Rosman AS, Restivo A et al (2012) Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 19(9):2822–2832